Tzvi Shir
Biographic Data
| ID | 5547210 |
|---|---|
| NAME | Tzvi Shir |
| GIVEN NAMES | Tzvi |
| FAMILY NAME | Shir |
| SIGNATURE | SHIR T |
| AFFILIATIONS | Clalit Health Services, Clalit Research Institute, Tel Aviv |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Why Is End-of-Life Spending So High? Evidence from Cancer Patients
We study the sources of high end-of-life spending for cancer patients. Even among patients with similar initial prognoses, spending in the year postdiagnosis is over twice as high for those who die within the year than those who survive. Elevated spending on decedents is predominantly driven by higher inpatient spending, particularly low-intensity admissions. However, most such admissions do not result in death, making it difficult to target spen…
Prediction Accuracy With Electronic Medical Records Versus Administrative Claims
OBJECTIVE: The objective of this study was to evaluate the incremental predictive power of electronic medical record (EMR) data, relative to the information available in more easily accessible and standardized insurance claims data. DATA AND METHODS: Using both EMR and Claims data, we predicted outcomes for 118,510 patients with 144,966 hospitalizations in 8 hospitals, using widely used prediction models. We use cross-validation to prevent overfi…
No prominent works on this page.
Prediction Accuracy With Electronic Medical Records Versus Administrative Claims
OBJECTIVE: The objective of this study was to evaluate the incremental predictive power of electronic medical record (EMR) data, relative to the information available in more easily accessible and standardized insurance claims data. DATA AND METHODS: Using both EMR and Claims data, we predicted outcomes for 118,510 patients with 144,966 hospitalizations in 8 hospitals, using widely used prediction models. We use cross-validation to prevent overfi…
Why Is End-of-Life Spending So High? Evidence from Cancer Patients
We study the sources of high end-of-life spending for cancer patients. Even among patients with similar initial prognoses, spending in the year postdiagnosis is over twice as high for those who die within the year than those who survive. Elevated spending on decedents is predominantly driven by higher inpatient spending, particularly low-intensity admissions. However, most such admissions do not result in death, making it difficult to target spen…
Internal Medicine (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Cancer (1 work) · Computer Science (1 work) · Data mining (1 work) · Demography (1 work) · Gerontology (1 work) · Gerontology (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work)